VEGFA and macular retinal edema: The above results suggest that the reason why the patients had better functional and anatomical improvements after surgery might be the synergistic effect from different mechanisms of dexamethasone intravitreal implants (anti-inflammatory drugs) and ranibizumab (anti-VEGF drugs), which resulted in faster, more pronounced and longer BCVA growth and improvement in macular edema.